Role for targeted resection in the multidisciplinary treatment of metastatic gastrointestinal stromal tumor

Bradford J. Kim, Daniel P. Milgrom, Cyrus Feizpour, Joshua K. Kays, Leonidas G. Koniaris

Research output: Contribution to journalReview article

1 Scopus citations

Abstract

The management of advanced gastrointestinal stromal tumors (GISTs) has evolved in the modern era due to the discovery of c-kit mutations and the development of tyrosine kinase inhibitors (TKIs). Until the advent of TKIs such as imatinib, the median survival reported for patients with advanced GIST was 19 months. Although surgery is the treatment of choice for resectable primary GIST, its role in cases of recurrence and metastasis remains to be unclear. This review outlines the potential beneficial role of repeat surgical resection in the multidisciplinary treatment of advanced GIST in the era of TKIs.

Original languageEnglish (US)
Article number26
JournalTranslational Gastroenterology and Hepatology
Volume4
Issue numberApril
DOIs
StatePublished - Apr 2019

Keywords

  • KIT
  • PDGFR
  • Resection

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Role for targeted resection in the multidisciplinary treatment of metastatic gastrointestinal stromal tumor'. Together they form a unique fingerprint.

  • Cite this